Report Examines PEPFAR Transition In South Africa
Health GAP and its partners on Wednesday released a report that “looks at the PEPFAR ‘transition’ in [South Africa] — moving from ‘directly supporting’ over one million people on ARV treatment in South Africa in early 2011 to a near complete withdrawal from support for ‘direct services.’ … The report finds that the political transition — toward increased South African ownership and innovative models of shared governance for U.S. funds — is yielding important benefits … [and] recommends an urgent course correction for PEPFAR South Africa — tracing patients and health workers while considering a more measured approach in the country,” according to press release. The report accompanies an article forthcoming in the Journal of Acquired Immune Deficiency Syndromes (1/15).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.